Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor
| Autor: | Wakamatsu, Sho, Jojima, Teruo, Hashiguchi, Masaaki, Kishi, Haruka, Niitani, Takafumi, Sakurai, Shintaro, Iijima, Toshie, Kogai, Takahiko, Tomaru, Takuya, Usui, Isao, Aso, Yoshimasa |
|---|---|
| Zdroj: | In Journal of Diabetes and Its Complications January 2024 38(1) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect